UnitedHealth Group, Boston Scientific, Medtronic and the University of Minnesota Work to Deploy 3,000 Emergency Ventilator Alternative Devices

UnitedHealth Group is collaborating with Boston Scientific, Medtronic and the University of Minnesota to deploy 3,000 newly invented “light” ventilators to address the limited stock of critical breathing support equipment in response to COVID-19.

UnitedHealth Group advises the collaboration went from concept stage to manufacturing in less than 30 days, with the first 500 products ready to ship this week. UnitedHealth Group is working with Medtronic and the University of Minnesota to determine initial destinations, while Boston Scientific is manufacturing and shipping the product.

These innovative devices will help address a clinical gap for patients who need a higher level of respiratory support but don’t have immediate access to traditional ventilators when there is a shortage. They will also provide health care workers with an additional tool to care for high volumes of patients who require emergency breathing support.

“We are grateful for collaborations with distinguished experts in academia, across health care and in other industries to offer innovative solutions like this light ventilator,” said Ken Ehlert, chief scientific officer, UnitedHealth Group. “Unique partnerships will be critical as we work together to confront COVID-19 in the months ahead. These light ventilators will help prevent future ventilation shortages, support patients who need this level of breathing assistance and expand clinical capacity to deliver care.”

The University of Minnesota Medical School and Earl E. Bakken Medical Devices Center initially conceived the idea of the light ventilator, called the Coventor. Boston Scientific, Medtronic and UnitedHealth Group provided technical, clinical, regulatory and manufacturing expertise to refine how the device works and bring it to market at scale.

“We are appreciative of the support locally and nationally in getting the Coventor to the field,” said Stephen Richardson, M.D., cardiac anesthesiology fellow at the University of Minnesota Medical School. “We developed the Coventor to be useful in those clinical settings where traditional ventilators are not available. This allows patients who wouldn’t otherwise have the opportunity to survive, to survive. Making the emergency ventilator alternative devices as fast as possible, pushing it to people everywhere — that’s what this is all about.”

The emergency ventilator alternative device uses an electrically powered robotic arm to mechanically compress an off-the-shelf adult resuscitation bag, the sort often used by paramedics to help a patient breathe. This design provides oxygen assistance and enables health care workers to shift from manually operating the resuscitation bag. The device can also be configured with airflow accessories in multiple ways to best accommodate on-the-ground needs at different clinical facilities.

The devices will be shipped to geographies where ventilators are urgently needed, and any remaining devices will be offered as a donation to the U.S. Strategic National Stockpile. Collaborating to deploy the emergency ventilator alternative is the latest of several initiatives announced by UnitedHealth Group to combat COVID-19. Other initiatives to date include:

  • Investing nearly $70 million to help at-risk populations and protect the health care workforce.
  • Pioneering self-administered swab procedures to expand COVID-19 testing, reduce needed personal protective equipment and protect health care workers from unnecessary exposure to COVID-19.
  • Accelerating payments to providers throughout the crisis, with an initial tranche of nearly $2 billion.
  • Waiving cost-sharing for COVID-19 testing and treatment for U.S. members of UnitedHealthcare plans and simplifying access to care by reducing prior-authorization requirements.
  • Significantly expanding access to telehealth and virtual visits and redeploying 5,000 Optum clinicians to expand telehealth capabilities.
  • Providing a special enrollment period for fully insured customers to allow employees who did not opt-in for coverage during the regular enrollment period to secure coverage.
  • Conducting proactive personal outreach to support seniors and the most vulnerable populations among our members.
  • Launching a free nationwide emotional-support line to manage the stress and anxiety caused by COVID-19.
  • Converting company cafeterias to provide more than 75,000 meals a week for people in need and keeping our cafe team at work.

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”
Exit mobile version